Heparin News and Research

RSS
Heparin, a highly-sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machines. Pharmaceutical grade heparin is derived from mucosal tissues of slaughtered meat animals such as porcine (pig) intestine or bovine (cow) lung.
Blacks less likely to get expensive, newer heart treatments

Blacks less likely to get expensive, newer heart treatments

Gene identified that confers susceptibility to age-related macular degeneration

Gene identified that confers susceptibility to age-related macular degeneration

Studies find Aspirin resistance in up to 27% of Aspirin users

Studies find Aspirin resistance in up to 27% of Aspirin users

Ximelagatran effective for preventing blood clots and stroke

Ximelagatran effective for preventing blood clots and stroke

New study details trends in diagnosis, treatment of brain tumours

New study details trends in diagnosis, treatment of brain tumours

Drug reviparin reduces the risk of death after heart attack

Drug reviparin reduces the risk of death after heart attack

New insight into anticoagulation therapies

New insight into anticoagulation therapies

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

Researchers have developed a novel drug-antidote pair

Researchers have developed a novel drug-antidote pair

Researchers discover mechanism that may help to explain how angiogenesis inhibitors work on normal, blood vessel-forming endothelial cells

Researchers discover mechanism that may help to explain how angiogenesis inhibitors work on normal, blood vessel-forming endothelial cells

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Anticoagulant therapy with enoxaparin is an effective alternative to heparin therapy for patients with acute coronary syndromes

Anticoagulant therapy with enoxaparin is an effective alternative to heparin therapy for patients with acute coronary syndromes

Anti-clotting treatment underused at many hospitals

Anti-clotting treatment underused at many hospitals

New and Generic Drug Approvals from FDA

New and Generic Drug Approvals from FDA

GlaxoSmithKline acquires injectable anti-thrombotic agents Fraxiparine® and Arixtra®

GlaxoSmithKline acquires injectable anti-thrombotic agents Fraxiparine® and Arixtra®

Forward step in treatment of Allergic Rhinitis

Forward step in treatment of Allergic Rhinitis